# Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.

> **NCT00813397** · NA · COMPLETED · sponsor: **Genzyme, a Sanofi Company** · enrollment: 210 (actual)

## Conditions studied

- Adhesion Prevention

## Interventions

- **DEVICE:** Sepraspray

## Key facts

- **NCT ID:** NCT00813397
- **Lead sponsor:** Genzyme, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 210 (ACTUAL)
- **Last updated:** 2015-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00813397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00813397, "Manageability and Safety Assessment of Sepraspray in Abdominal Surgery.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00813397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*